🔎 Trials Near Me

Home › Macular Degeneration › California › San Francisco

Macular Degeneration clinical trials in San Francisco, CA

5 studies for Macular Degeneration are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

RecruitingPhase 3
  • West Coast Retina Medical Group, Inc., San Francisco
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704

Village-Integrated Eye Worker Trial II

RecruitingHealthy volunteers welcome
  • University of California, San Francisco, San Francisco
Ages 60 and older · All sexes · Updated Jun 9, 2026 · NCT03752840

Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study

RecruitingObservational study
  • University of California, San Francisco, San Francisco
Ages 55 and older · All sexes · Updated Apr 29, 2026 · NCT07556406

Strategies for Improving Linkage-to-Care After Eye Disease Screening

Recruiting
  • University of California, San Francisco, San Francisco
Ages 60 and older · All sexes · Updated Apr 29, 2026 · NCT06943599

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

RecruitingPhase 3
  • West Coast Retina Medical Group, San Francisco
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759

About Macular Degeneration

Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.

More about Macular Degeneration on MedlinePlus

Macular Degeneration trials in other cities

Other studies in San Francisco

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.